The broad-spectrum antiviral spray is launched, which can be used for occupational protection of new coronavirus pneumonia emergency ward. Photo courtesy of Public Health Center
China News Online January 27 (Reporter Chen Jing) Reporter learned on the 27th from Shanghai Public Health Clinical Center affiliated to Fudan University that a scientific research team led by Xu Jianqing, director of the Xinfa and Reproducible Infectious Diseases Research Institute, lasted 6 years A broad-spectrum antiviral spray has been developed that can be used for occupational protection of new coronavirus pneumonia emergency wards and has passed ethical review.
The spray can be administered directly through the throat for a preventive effect. According to reports, the first batch of antiviral sprays have been sent to the emergency ward of the Shanghai Public Health Clinical Center. The public health center told reporters that the first time the product was received, Lu Hongzhou, an infectious disease expert and party secretary of the public health center, tried it in person. The reporter saw that the doctor opened his mouth to inhale, picked up the spray and sprayed it to the throat, only 0.5 ml to 1 ml each time, once in the morning and evening, can effectively prevent the new coronavirus.
It is reported that in order to effectively protect the safety of medical staff, the Public Health Center has tried every means to improve the medical conditions of medical staff in emergency wards. According to Xu Jianqing, all respiratory virus infections and their exacerbations have common pathogenic processes: inflammation caused by viral replication and respiratory epithelial mucosal damage. This antiviral spray is designed with two active ingredients, which can inhibit virus replication, inhibit inflammation and mucosal repair, and reach clinical application level. He said that the spray can inhibit RNA viruses, and the new coronavirus, as one of RNA viruses, is sensitive to the spray.
Because this spray requires a certain production process, it can only be supplied to frontline medical staff. Manufacturers only produce APIs. The research team also needs to prepare cans in a sterile environment according to the concentration used.